Dr David Williams – Invited Speaker Series
The Haemoglobinopathies in European Liaison of Medicine and Science (HELIOS) network will host a monthly speaker series with established researchers presenting a new approach to the diagnosis, treatment, guidelines and health economics of haemoglobinopathies.
The HELIOS network is committed to ensuring equal access to training on haemoglobinopathies for all.
The fifth speaker in the webinar series is Dr David Williams, researcher specializing in blood stem cell biology, leukemia, and gene therapy for genetic blood disorders.
We invite you to join us for this exciting opportunity to engage with the latest research in the field of haemoglobinopathies.
The speaker series is free of charge.
Additional Details
Speaker -
Speaker.
Dr. David Williams is an internationally renowned researcher specializing in blood stem cell biology, leukemia, and gene therapy for genetic blood disorders. He serves as the Leland Fikes Professor of Pediatrics at Harvard Medical School and Chief of Hematology/Oncology at Boston Children's Hospital. Dr. Williams' laboratory has been continuously funded by the NIH since 1986, reflecting his significant contributions to medical research. Throughout his career, he has mentored over 40 post-doctoral fellows, many of whom have established their own laboratories or joined the biotech and pharmaceutical industries.
Organizer
Stephanie Muth will host the monthly speaker series. Stephanie has worked for different medical device companies since 2010, breaking down barriers to introduce new treatment options to patients. She is passionate about collaborating with interdisciplinary stakeholders to improve the diagnosis and care available to patients. Since March 2022, Stephanie works with Resonance Health who provide FerriScan, the gold standard for liver iron concentration (LIC) measurements in haemoglobinopathy patients.
